A detailed history of Farallon Capital Management LLC transactions in Biodesix Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 4,636,791 shares of BDSX stock, worth $6.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,636,791
Previous 1,878,175 146.88%
Holding current value
$6.4 Million
Previous $2.87 Million 187.26%
% of portfolio
0.04%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.53 - $1.96 $4.22 Million - $5.41 Million
2,758,616 Added 146.88%
4,636,791 $8.25 Million
Q2 2024

Aug 14, 2024

BUY
$1.21 - $1.71 $2.27 Million - $3.21 Million
1,878,175 New
1,878,175 $2.87 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.